The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement

Last updated: August 7, 2012
Sponsor: Siriraj Hospital
Overall Status: Trial Status Unknown

Phase

1/2

Condition

Hair Loss

Alopecia

Treatment

N/A

Clinical Study ID

NCT01662089
SirirajH-004
  • Ages > 18
  • Female

Study Summary

Zinc supplement is a popular trace element gave to Female pattern hair loss (FPHL) patient. But the type of patient, efficacy, and side effect in detail of zinc supplement are not well characterized. The purpose of this study is to determine efficacy and side effect of chelated zinc in FPHL who using 5%minoxidil solution.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female Pattern Hair Loss ( Ludwig classification grade 1 and 2 )

Exclusion

Exclusion Criteria:

  • Underlying disease ; Anemia, Diabetes, chronic alcoholism, previous gastrointestinalsurgery, short bowel syndrome, Crohn's disease, digestive disorder,hypo/hyperthyroidism, sickle cell disease, autoimmune disease, iron deficiency

  • Psychologic disorder trichotillomania

  • Diet control

  • Pregnancy or lactation

  • On supplement diet within 3 month prior to trial

Study Design

Total Participants: 20
Study Start date:
January 01, 2012
Estimated Completion Date:
December 31, 2012

Study Description

5%minoxidil solution is standard treatment for Female pattern hair loss (FPHL) patient. We gave 15mg chelate Zinc / Placebo drug to patient as an additional trace element. Then measure growth of hair by Global photograph, Microscope hair count, micrometer and record case and side effect during 10 months of treatment.

Connect with a study center

  • Siriraj Hospital

    Bangkok, 10700
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.